Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Developing FGFR inhibitors as potential anti-cancer agents].

Acta pharmaceutica Hungarica - 1 Jan 2013

Zsákai Lilian, Németh Gábor, Szántai-Kis Csaba, Greff Zoltán, Horváth Zoltán, Szokol Bálint, Baska Ferenc, Boon Tin Chuad, Orfi Lászlo, Kéri Györgya

Abstract excerpt

Fibroblast Growth Factor Receptor (FGFR) family is a sequentially highly related subgroup of membrane proteins consisting of four tyrosine kinase type enzyme: FGFR1, FGFR2, FGFR3 and FGFR4. These are kinases of great interest in a wide spectrum of physiological processes such as tissue repair via controlling cell proliferation. As initiatiors of cell proliferation, in some cases they have leading roles in several...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cell Movement

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Survival

Share to Computer Simulation

Share to Indoles

Share to Receptors, Fibroblast Growth Factor

Share to Thiophenes

Share to Up-Regulation

Source

Identifiers

PMID: 23926649

Genes

FGFR1
FGFR2
FGFR3
FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Developing FGFR inhibitors as potential anti-cancer agents].PMID 23926649Read ↗

FGFR a promising druggable target in cancer: Molecular biology and new drugs.Semantic proximity Read ↗

Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.Semantic proximity Read ↗

A Structure-Guided Approach to Creating Covalent FGFR InhibitorsSemantic proximity Read ↗

Future applications of FGF/FGFR inhibitors in cancer.Semantic proximity Read ↗

Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.Semantic proximity Read ↗

Molecular Targeting of the Fibroblast Growth Factor Receptor (FGFR) Pathway Across Various CancersSemantic proximity Read ↗

Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019).Semantic proximity Read ↗

Discovery of Substituted 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine Derivatives as Potent and Selective FGFR Kinase InhibitorsSemantic proximity Read ↗

Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in CancerSemantic proximity Read ↗

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignanciesSemantic proximity Read ↗

Synthesis and in vitro biological evaluation of novel quinazoline derivatives.Semantic proximity Read ↗

Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer AgentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.